Peptide Evidence Briefs
One focused question at a time.
Each brief checks a public claim against FDA, FTC, or original research sources. It explains what the source supports and what is still unknown.
Published briefs
Read the claim, source, limits, and next question.
These briefs teach a research method. They do not tell you which product to use or make a personal medical decision.
01020304
A peptide name does not identify a finished product
A study and an online product may share a name while differing in important ways.
What FDA currently says about BPC-157 compounding risk
FDA reports limited safety information and concerns about peptide quality and immune reactions.
What “compounded” means
Compounding can meet a patient need, but a compounded drug is not FDA-approved.
A “research use only” disclaimer cannot carry the whole page
Regulators look at the full sales message, not only one line of disclaimer text.
Education only